4//SEC Filing
Panzara Michael A. 4
Accession 0001209191-22-032681
CIK 0001620463other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:38 PM ET
Size
5.5 KB
Accession
0001209191-22-032681
Insider Transaction Report
Form 4
Panzara Michael A.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-20+2,311→ 2,311 totalExercise: $8.93Exp: 2032-05-19→ Common Stock (2,311 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 20, 2023, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 20, 2022. The option reported was granted pursuant to the terms of the Issuer's outside director compensation policy.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001679039
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:38 PM ET
- Size
- 5.5 KB